Let's take a look at it slowly. Alopecia Areata, an autoimmune disease, and the therapeutic effect so far are well organized. You can just look at the data. In the Anglo-American world, with FDA approval, JAK inhibitor and jack-inhibitor are becoming familiar terms.
https://youtu.be/3FgkcgOfja4
Six pharmaceutical companies have been licensed, and thanks to the unique U.S. system, they are at war in their own markets. It's a special program, and it's a monthly fee of 5 dollars through screening.
Currently, the United States, Europe, and Japan have approved it.
Comments 2